| Year |
Citation |
Score |
| 2019 |
Kranzler HR, Feinn R, Morris P, Hartwell EE. A Meta-analysis of the Efficacy of Gabapentin for Treating Alcohol Use Disorder. Addiction (Abingdon, England). PMID 31077485 DOI: 10.1111/Add.14655 |
0.304 |
|
| 2017 |
Yang BZ, Arias AJ, Feinn R, Krystal JH, Gelernter J, Petrakis IL. GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers. Alcoholism, Clinical and Experimental Research. PMID 29131352 DOI: 10.1111/Acer.13516 |
0.302 |
|
| 2016 |
Feinn R, Curtis B, Kranzler HR. Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care. The Journal of Clinical Psychiatry. PMID 26891181 DOI: 10.4088/Jcp.15M10053 |
0.303 |
|
| 2014 |
Kranzler HR, Armeli S, Feinn R, Tennen H, Gelernter J, Covault J. GRIK1 genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1549-56. PMID 24786948 DOI: 10.1017/S1461145714000510 |
0.323 |
|
| 2014 |
Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, Gelernter J, Pond T, Oncken C, Kampman KM. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. The American Journal of Psychiatry. 171: 445-52. PMID 24525690 DOI: 10.1176/Appi.Ajp.2013.13081014 |
0.309 |
|
| 2011 |
Kranzler HR, Armeli S, Tennen H, Covault J, Feinn R, Arias AJ, Pettinati H, Oncken C. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype. Journal of Clinical Psychopharmacology. 31: 22-30. PMID 21192139 DOI: 10.1097/Jcp.0B013E31820465Fa |
0.324 |
|
| 2010 |
Arias AJ, Feinn R, Oncken C, Covault J, Kranzler HR. Placebo-controlled trial of zonisamide for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 30: 318-22. PMID 20473070 DOI: 10.1097/Jcp.0B013E3181Db38Bb |
0.306 |
|
| 2007 |
Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence. 86: 214-21. PMID 16919401 DOI: 10.1016/J.Drugalcdep.2006.06.008 |
0.316 |
|
| 2007 |
Arias AJ, Feinn R, Covault J, Kranzler HR. Memantine for alcohol dependence: An open-label pilot study Addictive Disorders and Their Treatment. 6: 77-83. DOI: 10.1097/01.Adt.0000210724.41187.4A |
0.318 |
|
| 2006 |
Armeli S, Feinn R, Tennen H, Kranzler HR. The effects of naltrexone on alcohol consumption and affect reactivity to daily interpersonal events among heavy drinkers. Experimental and Clinical Psychopharmacology. 14: 199-208. PMID 16756424 DOI: 10.1037/1064-1297.14.2.199 |
0.304 |
|
| 2006 |
Pierucci-Lagha A, Covault J, Feinn R, Khisti RT, Morrow AL, Marx CE, Shampine LJ, Kranzler HR. Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. Psychopharmacology. 186: 451-61. PMID 16341848 DOI: 10.1007/S00213-005-0231-0 |
0.304 |
|
| 2005 |
Feinn R, Kranzler HR. Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies? Alcoholism, Clinical and Experimental Research. 29: 983-8. PMID 15976524 DOI: 10.1097/01.Alc.0000171061.03686.Bc |
0.301 |
|
| 2005 |
Pierucci-Lagha A, Covault J, Feinn R, Nellissery M, Hernandez-Avila C, Oncken C, Morrow AL, Kranzler HR. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1193-203. PMID 15702134 DOI: 10.1038/Sj.Npp.1300688 |
0.312 |
|
| 2004 |
Hernandez-Avila CA, Modesto-Lowe V, Feinn R, Kranzler HR. Nefazodone treatment of comorbid alcohol dependence and major depression. Alcoholism, Clinical and Experimental Research. 28: 433-40. PMID 15084901 DOI: 10.1097/01.Alc.0000118313.63897.Ee |
0.303 |
|
| 2004 |
Pierucci-Lagha A, Feinn R, Modesto-Lowe V, Swift R, Nellissery M, Covault J, Kranzler HR. Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence. Psychopharmacology. 171: 340-8. PMID 13680073 DOI: 10.1007/S00213-003-1588-6 |
0.328 |
|
| 2003 |
Kranzler HR, Pierucci-Lagha A, Feinn R, Hernandez-Avila C. Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study. Alcoholism, Clinical and Experimental Research. 27: 1150-5. PMID 12878921 DOI: 10.1097/01.Alc.0000075547.77464.76 |
0.321 |
|
| 2003 |
Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R. Targeted naltrexone for early problem drinkers. Journal of Clinical Psychopharmacology. 23: 294-304. PMID 12826991 DOI: 10.1097/01.Jcp.0000084030.22282.6D |
0.314 |
|
| Show low-probability matches. |